EnteroMedics (ETRM) Reports Q3 Loss of $0.40
EnteroMedics, Inc. (ETRM) reports Q3 loss of $0.40, cents better than the analyst estimate of ($0.22).
Stocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
